General Information of the Compound
| Compound ID |
CP0960360
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-2-(8-(azetidin-3-yloxy)-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(4-chloro-3-fluorophenyl)ethyl)acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H18ClFN6O3
|
||||||||||||||||||
| Molecular Weight |
420.832
|
||||||||||||||||||
| Canonical SMILES |
C[C@H](NC(=O)Cn1nc2c(OC3CNC3)nccn2c1=O)c1ccc(Cl)c(F)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H18ClFN6O3/c1-10(11-2-3-13(19)14(20)6-11)23-15(27)9-26-18(28)25-5-4-22-17(16(25)24-26)29-12-7-21-8-12/h2-6,10,12,21H,7-9H2,1H3,(H,23,27)/t10-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XRVVLMSYWXDFQD-JTQLQIEISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06277, Probable G-protein coupled receptor 139
Protein ID: PT06789, Probable G-protein coupled receptor 139